{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T02:30:45Z","timestamp":1777170645132,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bbrc.2020.10.106","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T09:37:15Z","timestamp":1604569035000},"page":"795-801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The Rho kinase 2 (ROCK2)-specific inhibitor KD025 ameliorates the development of pulmonary arterial hypertension"],"prefix":"10.1016","volume":"534","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4718-4471","authenticated-orcid":false,"given":"Aya","family":"Yamamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Junayed","family":"Nayeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2020.10.106_bib1","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.jacc.2015.03.540","article-title":"Management of pulmonary arterial hypertension","volume":"65","author":"McLaughlin","year":"2015","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2020.10.106_bib2","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jacc.2009.04.018","article-title":"Cellular and molecular basis of pulmonary arterial hypertension","volume":"54","author":"Morrell","year":"2009","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2020.10.106_bib3","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1253\/circj.CJ-66-0158","article-title":"Guidelines for the treatment of pulmonary hypertension (JCS 2017\/JPCPHS 2017)","volume":"83","author":"Fukuda","year":"2019","journal-title":"Circ. J."},{"key":"10.1016\/j.bbrc.2020.10.106_bib4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCRESAHA.115.306532","article-title":"RhoA\/Rho-kinase in the cardiovascular system","volume":"118","author":"Shimokawa","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2020.10.106_bib5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fphar.2015.00276","article-title":"The function of Rho-associated kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease","volume":"6","author":"Hartmann","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2020.10.106_bib6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.pharmthera.2012.12.003","article-title":"Role of Rho-kinase and its inhibitors in pulmonary hypertension","volume":"137","author":"Duong-Quy","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2020.10.106_bib7","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/01.CIR.98.14.1400","article-title":"Dysfunctional voltage-gated K+ channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension","volume":"98","author":"Yuan","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2020.10.106_bib8","doi-asserted-by":"crossref","first-page":"13861","DOI":"10.1073\/pnas.0405908101","article-title":"Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension","volume":"101","author":"Yu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2020.10.106_bib9","doi-asserted-by":"crossref","first-page":"7363","DOI":"10.1096\/fj.201802620R","article-title":"Platelet-derived growth factor up-regulates Ca2+-sensing receptors in idiopathic pulmonary arterial hypertension","volume":"33","author":"Yamamura","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2020.10.106_bib10","doi-asserted-by":"crossref","first-page":"17766","DOI":"10.1074\/jbc.M111.219816","article-title":"Identification of transcription factor E3 (TFE3) as a receptor-independent activator of G\u03b116: gene regulation by nuclear G\u03b1 subunit and its activator","volume":"286","author":"Sato","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.10.106_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12576-020-00773-y","article-title":"Hypoxia induces the translocation of glucose transporter 1 to the plasma membrane in vascular endothelial cells","volume":"70","author":"Mamun","year":"2020","journal-title":"J.\u00a0Physiol. Sci."},{"key":"10.1016\/j.bbrc.2020.10.106_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138384","article-title":"Inhibition of excessive cell proliferation by calcilytics in idiopathic pulmonary arterial hypertension","volume":"10","author":"Yamamura","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.bbrc.2020.10.106_bib13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/CIRCRESAHA.112.266361","article-title":"Enhanced Ca2+-sensing receptor function in idiopathic pulmonary arterial hypertension","volume":"111","author":"Yamamura","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2020.10.106_bib14","doi-asserted-by":"crossref","first-page":"L846","DOI":"10.1152\/ajplung.00050.2016","article-title":"Pathogenic role of calcium-sensing receptors in the development and progression of pulmonary hypertension","volume":"310","author":"Tang","year":"2016","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.bbrc.2020.10.106_bib15","doi-asserted-by":"crossref","first-page":"C373","DOI":"10.1152\/ajpcell.00115.2014","article-title":"Flow shear stress enhances intracellular Ca2+ signaling in pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension","volume":"307","author":"Song","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbrc.2020.10.106_bib16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1165\/rcmb.2014-0235OC","article-title":"Notch activation of Ca2+ signaling in the development of hypoxic pulmonary vasoconstriction and pulmonary hypertension","volume":"53","author":"Smith","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbrc.2020.10.106_bib17","doi-asserted-by":"crossref","first-page":"L10","DOI":"10.1152\/ajplung.00010.2019","article-title":"MicroRNA-mediated downregulation of K+ channels in pulmonary arterial hypertension","volume":"318","author":"Babicheva","year":"2020","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.bbrc.2020.10.106_bib18","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.drudis.2013.09.010","article-title":"Advances in the development of Rho-associated protein kinase (ROCK) inhibitors","volume":"18","author":"Pan","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbrc.2020.10.106_bib19","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1161\/ATVBAHA.113.301357","article-title":"Crucial role of ROCK2 in vascular smooth muscle cells for hypoxia-induced pulmonary hypertension in mice","volume":"33","author":"Shimizu","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2020.10.106_bib20","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.3892\/etm.2016.3214","article-title":"ROCK2 mediates the proliferation of pulmonary arterial endothelial cells induced by hypoxia in the development of pulmonary arterial hypertension","volume":"11","author":"Qiao","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbrc.2020.10.106_bib21","doi-asserted-by":"crossref","first-page":"9356","DOI":"10.1038\/s41598-018-27321-4","article-title":"The level of ROCK1 and ROCK2 in patients with pulmonary hypertension in plateau area","volume":"8","author":"Liu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2020.10.106_bib22","doi-asserted-by":"crossref","first-page":"E7129","DOI":"10.1073\/pnas.1721298115","article-title":"Different roles of myocardial ROCK1 and ROCK2 in cardiac dysfunction and postcapillary pulmonary hypertension in mice","volume":"115","author":"Sunamura","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2020.10.106_bib23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/acn3.19","article-title":"Selective ROCK2 inhibition in focal cerebral ischemia","volume":"1","author":"Lee","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.bbrc.2020.10.106_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/FJC.0b013e3182a3718f","article-title":"Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil","volume":"62","author":"Shi","year":"2013","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bbrc.2020.10.106_bib25","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.drudis.2019.11.017","article-title":"ROCK-2-selective targeting and its therapeutic outcomes","volume":"25","author":"Sharma","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbrc.2020.10.106_bib26","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/acn3.569","article-title":"Rho-kinase inhibitors do not expand hematoma volume in acute experimental intracerebral hemorrhage","volume":"5","author":"Akhter","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.bbrc.2020.10.106_bib27","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCRESAHA.119.316141","article-title":"PTH\/PTHrP receptor signaling restricts arterial fibrosis in diabetic LDLR-\/- mice by inhibiting myocardin-related transcription factor relays","volume":"126","author":"Behrmann","year":"2020","journal-title":"Circ. Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20320350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20320350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:09:13Z","timestamp":1757765353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X20320350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":27,"alternative-id":["S0006291X20320350"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.10.106","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Rho kinase 2 (ROCK2)-specific inhibitor KD025 ameliorates the development of pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.10.106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}